News

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...
Let-7 gene is a key guardian of healthy lungs that keeps pulmonary fibrosis in check, study finds
Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...
Mirage News20h
Let-7: Key Guardian of Lungs, Checks Pulmonary Fibrosis
Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...
Pharmaceutical Technology53m
FDA clears Ensoma’s application for rare genetic disorder treatment
The FDA has cleared the IND for Ensoma's EN-374, targeting X-linked chronic granulomatous disease (X-CGD), a rare genetic ...
Taiwan News17h
Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT to address mast cell driven ...
Medindia5h
MavriX Bio Announces FDA Clearance of IND Application to Initiate First-in-Human Study of Gene Therapy for Angelman Syndrome
MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug Administration ...